Director Nicholas Glover of Lite Strategy, Inc. filed a Form 4 on October 26, 2026, disclosing two open-market purchases of common stock and a stock option grant made between July 22 and October 22, 2026.

Key Highlights

  • First purchase: Glover acquired 1,000 shares of common stock on July 22, 2025, at $6.55 per share.
  • Second purchase: Glover acquired an additional 1,000 shares on July 23, 2025, at $6.00 per share, bringing his direct beneficial ownership to 2,000 shares.
  • Stock option grant: Glover received a stock option to purchase 100,000 shares of common stock at an exercise price of $1.19, with an expiration date of October 22, 2036.
  • Option vesting: According to the filing, 25.0% of the options vested on the date of grant, with the remainder vesting in nine equal monthly installments such that the award becomes fully vested on June 30.
  • Option basis: The filing notes the option was received "as compensation for service on the Board" and describes it as a "customary annual grant to non-employee directors."
  • Ownership form: All reported securities are held directly by Glover.

Nicholas Glover's Common Stock Purchases and Director Option Award at Lite Strategy

According to the Form 4 filed with the SEC on October 26, 2026, Nicholas Glover, identified as a Director of Lite Strategy, Inc. (NASDAQ:LITS), reported three transactions involving the company's securities. The filing covers activity beginning July 22, 2025, as the date of the earliest transaction.

In Table I, the filing discloses two open-market purchases of common stock coded as "P" (purchases). On July 22, 2025, Glover acquired 1,000 shares at $6.55 per share, and on July 23, 2025, he acquired another 1,000 shares at $6.00 per share. Following these transactions, his direct beneficial ownership of common stock stood at 2,000 shares, the filing states.

In Table II, the filing reports a stock option grant coded "A" (acquired), covering 100,000 shares of common stock at an exercise price of $1.19. The filing notes the price of the derivative security as $0 and describes the grant as a "customary annual grant to non-employee directors of options to purchase shares of common stock." The option is exercisable beginning October 22, 2026, and expires October 22, 2036. Per the filing's explanation of responses, 25.0% of the options vested on the grant date, with the remaining shares vesting in nine equal monthly installments on the last day of each calendar month, becoming fully vested on June 30. Following the grant, Glover's direct beneficial ownership of this derivative security is reported as 100,000 options.

What Was Disclosed

The filing reports two open-market purchases totaling 2,000 shares of Lite Strategy common stock and one stock option grant for 100,000 shares, all held directly by Director Nicholas Glover, with the option described as an annual non-employee director award.